Keywords: updated, story, launch, february, cephalon, narcolepsy, treatment
UPDATED STORY - US launch in February for Cephalon's narcolepsy treatment
Article | 06 January 1999
The US Food and Drug Administration has approved Cephalon's Provigil(modafinil) tablets for the first-line treatment of excessive daytime sleepiness ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
